期刊文献+

浅谈心房颤动的研究与进展 被引量:1

原文传递
导出
摘要 心房颤动简称房颤,是最常见的持续性心律失常,房颤总的发病率为0.4%,随着年龄增长房颤的发生率不断增加,75岁以上人群可达10%.房颤时心房激动的频率达300~600次/分,心跳频率往往快而且不规则,有时候可以达到100~160次/分,不仅比正常人心跳快得多,而且绝对不整齐,心房失去有效的收缩功能.我国大规模调查研究显示房颤患病率为0.77%,男性房颤患病率(0.9%)高于女性(0.7%),80岁以上房颤患病率达7.5%.此外房颤患病率的增长还会与冠心病、高血压病和心力衰竭等疾病的增长密切相关,未来50年房颤将成为最流行的心血管疾病之一.
作者 刘忠喜
出处 《按摩与康复医学》 2012年第11期44-44,共1页 Chinese Manipulation and Rehabilitation Medicine
  • 相关文献

参考文献2

二级参考文献29

  • 1毕亚艳,李智博,黄永麟.无症状心房颤动的临床意义及处理[J].中华心律失常学杂志,2006,10(5):361-363. 被引量:1
  • 2Waldo AL. Management of atrial fibrillation : the need for AFFIRMative action.AFFIRM investigators. Atrial Fibrillation Follow-up Investigation of Rhythm Management [ J ]. Am J Cardiol, 1999,84 ( 6 ) :698 -700.
  • 3Wyse DG, Wahto AL, DiMareo JP, et al. Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators [ J ]. N Engl J Med,2002, 347(23) :1825-1833.
  • 4van Gelder IC, Hagens VE, Bosker HA,et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation[ J]. N Engl J Med, 2002,347 ( 23 ) : 1834 -1840.
  • 5Cleland JG, Coletta AP, Abdellah AT, et al. Clinical trials update from the American Heart Association 2007 : CORONA, RethinQ, MASCOT, AF-CHF, HART, MASTER,POISE and stem cell therapy [ J ]. Eur J Heart Fail, 2008,10 ( 1 ) : 102-108.
  • 6Singh BN, Vaughan Williams EM. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle [ J ]. Br J Pharmacol, 1970,39 ( 4 ) :657-667.
  • 7Vorperian VR, Havighurst TC, Miller S, et al. Adverse effects of low dose amiodarone : a meta-analysis [ J ]. J Am Coll Cardiol, 1997,30 ( 3 ) : 791-798.
  • 8Sun W,Sarma JS,Singh BN. Electrophysiological effects of dronedarone ( SR33589), a noniodinated benzofuran derivative, in the rabbit heart : comparison with amiodarone [ J ]. Circulation, 1999,100 ( 22 ) : 2276 -2281.
  • 9Singh BN, Connotly SJ, Crijns HJ, et al. EURIDIS and ADONIS Investigators Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter[ J ]. N Engl J Med,2007,357(10) :987-999.
  • 10Kober L. Antiarrhythmic Trial With Dronedarone in Moderate to Severe CHF Evaluating Morbidity Decrease (ANDROMEDA), NCT00543699. Terminated Jan 2003. Available at : http ://clinicahrials. Gov/ct2/show/record/NCTO0543699. Accessed December 14,2007.

共引文献17

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部